Pembrolizumab/carboplatin/pemetrexedLack of efficacy and fulminant type-1 diabetes: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1852卷 / 1期
关键词：
D O I：
10.1007/s40278-021-94811-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：358 / 358
相关论文
共 50 条
  • [31] Carboplatin/pemetrexedLack of efficacy: 2 case reports
    Reactions Weekly, 2022, 1913 (1) : 133 - 133
  • [32] Fulminant type 1 diabetes mellitus induced by pembrolizumab in a patient with urothelial carcinoma: A case report
    Tohi, Yoichiro
    Fujimoto, Kanta
    Suzuki, Ryosuke
    Suzuki, Issei
    Kubota, Masashi
    Kawakita, Mutsushi
    UROLOGY CASE REPORTS, 2019, 24
  • [33] PemetrexedLack of efficacy: case report
    Reactions Weekly, 2023, 1952 (1) : 291 - 291
  • [34] PemetrexedLack of efficacy: case report
    Reactions Weekly, 2022, 1933 (1) : 371 - 371
  • [35] Cisplatin/pembrolizumab/pemetrexedLack of efficacy, pneumonitis and sarcoidosis-like reactions: case report
    Reactions Weekly, 2023, 1962 (1) : 138 - 138
  • [36] Fulminant type 1 diabetes mellitus: a case report
    Yunir, E.
    Nenfiati
    1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA, 2018, 125
  • [37] Fulminant type 1 diabetes mellitus associated with pembrolizumab
    Mizab Mellah, Chadia
    Sanchez Perez, Marta
    Santos Rey, Maria Dolores
    Hernandez Garcia, Marta
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2017, 64 (05): : 272 - 273
  • [38] Cisplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2022, 1895 (1) : 139 - 139
  • [39] Pembrolizumab: An unlikely cause of Type-1 Diabetes?
    Iqbal, Arham
    Iqbal, Unzela
    Abbasi, Zaeem Ahmed
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (02) : 396 - 396
  • [40] Cisplatin/pemetrexedLack of efficacy : case report
    Reactions Weekly, 2023, 1944 (1) : 204 - 204
12345